Characteristics of exercise intolerance in different subgroups of pulmonary arterial hypertension associated with congenital heart disease

被引:2
|
作者
Zhang, Hong-Da [1 ]
Yan, Yi [2 ,3 ]
He, Yang-Yang [4 ]
Liu, Qian-Qian [1 ]
Peng, Fu-Hua [1 ]
Yan, Xin-Xin [1 ]
Han, Zhi-Yan [1 ,5 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Beijing 100037, Peoples R China
[2] Shanghai Jiao Tong Univ, Heart Ctr, Shanghai Childrens Med Ctr, Sch Med, Shanghai 200127, Peoples R China
[3] Shanghai Jiao Tong Univ, Shanghai Inst Pediat Congenital Heart Dis, Sch Med, Shanghai 200127, Peoples R China
[4] Henan Univ, Sch Pharm, Kaifeng 475004, Peoples R China
[5] Fuwai Hosp, Chinese Acad Med Sci, Peking Union Med Coll, Natl Ctr Cardiovasc Dis,Dept Anesthesiol,State Key, 167 Beilishi Rd, Beijing 100037, Peoples R China
基金
中国国家自然科学基金; 中国博士后科学基金;
关键词
Pulmonary arterial hypertension; Congenital heart disease; Exercise intolerance; Cardiopulmonary exercise testing; Peak oxygen uptake; EISENMENGER SYNDROME; ADULTS; SURVIVAL; ERA;
D O I
10.1016/j.ijcard.2022.12.033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Exercise intolerance is a major manifestation of pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD). We aimed to investigate the characteristics of exercise intolerance in different subgroups of PAH-CHD. Methods: We retrospectively enrolled 171 adult patients with PAH-CHD and 30 age and sex-matched healthy subjects and performed cardiopulmonary exercise testing. Gas exchange parameters, including peak oxygen uptake (peak VO2), anaerobic threshold, and the slope of ventilatory equivalent for carbon dioxide (VE/VCO2 slope), were recorded. Results: The median age of patients at enrollment was 27.8 years, and 131 (76.6%) were female. Peak VO2 was reduced in patients compared to healthy controls (median, 14.8 ml/kg/min versus 26.9 ml/kg/min, p < 0.001). Of all 171 patients, 60 (35.1%) had Eisenmenger syndrome, 35 (20.5%) had PAH associated with systemic-to-pulmonary shunts (PAH-SP), 39 (22.8%) had PAH with small defects (PAH-SD), and 37 (21.6%) had PAH after cardiac defect correction (PAH-CD). Patients with Eisenmenger syndrome had the lowest peak VO2 (p = 0.003) and the highest VE/VCO2 slope (p = 0.012), compared with other patients, representing the worst exercise capacity and ventilatory efficiency. Patients with PAH-SP had the best exercise capacity among the four groups, indicated by the highest peak VO2 (p = 0.003) compared with other patients. Peak VO2 was negatively correlated with pulmonary vascular resistance (r =-0.411, p < 0.001). Conclusions: Exercise capacity was severely reduced in patients with PAH-CHD. Among the four subgroups, patients with Eisenmenger syndrome had the worst exercise capacity and ventilatory efficiency.
引用
收藏
页码:29 / 35
页数:7
相关论文
共 50 条
  • [1] Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease
    Becker-Gruenig, Tabea
    Klose, Hans
    Ehlken, Nicola
    Lichtblau, Mona
    Nagel, Christian
    Fischer, Christine
    Gorenflo, Matthias
    Tiede, Henning
    Schranz, Dietmar
    Hager, Alfred
    Kaemmerer, Harald
    Miera, Oliver
    Ulrich, Silvia
    Speich, Rudolf
    Uiker, Soeren
    Gruenig, Ekkehard
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 375 - 381
  • [2] Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Zuckerman W.A.
    Krishnan U.
    Rosenzweig E.B.
    Current Pediatrics Reports, 2013, 1 (2) : 92 - 101
  • [3] Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Krishnan, Usha
    Rosenzweig, Erika B.
    CLINICS IN CHEST MEDICINE, 2013, 34 (04) : 707 - +
  • [4] Pulmonary arterial hypertension in congenital heart disease
    Ferrero, Paolo
    Krishnathasan, Kaushiga
    Constantine, Andrew
    Chessa, Massimo
    Dimopoulos, Konstantinos
    HEART, 2024, 110 (18) : 1145 - 1152
  • [5] The Challenges in Managing Pulmonary Arterial Hypertension Associated with Congenital Heart Disease
    Lu, Chun-Wei
    ACTA CARDIOLOGICA SINICA, 2015, 31 (06) : 516 - 517
  • [6] Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
    Savale, Laurent
    Manes, Alessandra
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0K) : 37 - 45
  • [7] Pulmonary arterial hypertension in congenital heart disease - Part I
    Kaemmerer, Harald
    Diller, Gerhard Paul
    Daehnert, Ingo
    Eichstaedt, Christina A.
    Eicken, Andreas
    Freiberger, Annika
    Freilinger, Sebastian
    Geiger, Ralf
    Gorenflo, Matthias
    Gruenig, Ekkehard
    Hager, Alfred
    Herberg, Ulrike
    Huntgeburth, Michael
    Kaemmerer, Ann-Sophie
    Kozlik-Feldmann, Rainer
    Lammers, Astrid
    Nagdyman, Nicole
    Michel, Sebastian
    Schmidt, Kai Helge
    Uebing, Anselm
    von Scheidt, Fabian
    Apitz, Christian
    PNEUMOLOGIE, 2023, 77 (11): : 956 - 961
  • [8] Congenital Heart Disease-Associated Pulmonary Hypertension
    Rosenzweig, Erika B.
    Krishnan, Usha
    CLINICS IN CHEST MEDICINE, 2021, 42 (01) : 9 - 18
  • [9] Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
    Lopes, Antonio
    Alnajashi, Khalid
    ANNALS OF THORACIC MEDICINE, 2014, 9 (05) : 21 - 25
  • [10] Clinical classification in pediatric pulmonary arterial hypertension associated with congenital heart disease
    Zijlstra, Willemijn M. H.
    Douwes, Johannes M.
    Ploegstra, Mark-Jan
    Krishnan, Usha
    Roofthooft, Marcus T. R.
    Hillege, Hans L.
    Ivy, D. Dunbar
    Rosenzweig, Erika B.
    Berger, Rolf M. F.
    PULMONARY CIRCULATION, 2016, 6 (03) : 302 - 312